The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Blood Coagulants-Global Market Insights and Sales Trends 2024
Synopsis
Coagulation is the process, by which blood changes from a liquid to a gel, forming a blood clot. In general terms, coagulation is a process in which the blood forms clots to block and then heal a lesion/wound/cut and stop the bleeding.
The global Blood Coagulants market size is expected to reach US$ 628.6 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Coagulants in various end use industries. The expanding demands from the Hospital, Pharmacy and Other, are propelling Blood Coagulants market. Recombinant Coagulation Factor, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasma Coagulation Factor segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Sale Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Coagulants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Coagulants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Coagulants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Coagulants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Coagulants covered in this report include Pfizer, Bayer, Novo Nordisk, Takeda, SOBI, Octapharma and CSL, etc.
The global Blood Coagulants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Bayer
Novo Nordisk
Takeda
SOBI
Octapharma
CSL
Global Blood Coagulants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Coagulants market, Segment by Type:
Recombinant Coagulation Factor
Plasma Coagulation Factor
Global Blood Coagulants market, by Sale Channel
Hospital
Pharmacy
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Blood Coagulants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Blood Coagulants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Sale Channel, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Coagulation is the process, by which blood changes from a liquid to a gel, forming a blood clot. In general terms, coagulation is a process in which the blood forms clots to block and then heal a lesion/wound/cut and stop the bleeding.
The global Blood Coagulants market size is expected to reach US$ 628.6 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Coagulants in various end use industries. The expanding demands from the Hospital, Pharmacy and Other, are propelling Blood Coagulants market. Recombinant Coagulation Factor, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasma Coagulation Factor segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Sale Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Coagulants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Coagulants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Coagulants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Coagulants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Coagulants covered in this report include Pfizer, Bayer, Novo Nordisk, Takeda, SOBI, Octapharma and CSL, etc.
The global Blood Coagulants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Bayer
Novo Nordisk
Takeda
SOBI
Octapharma
CSL
Global Blood Coagulants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Coagulants market, Segment by Type:
Recombinant Coagulation Factor
Plasma Coagulation Factor
Global Blood Coagulants market, by Sale Channel
Hospital
Pharmacy
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Blood Coagulants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Blood Coagulants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Sale Channel, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Blood Coagulants Market Overview
1.1 Blood Coagulants Product Overview
1.2 Blood Coagulants Market Segment by Type
1.2.1 Recombinant Coagulation Factor
1.2.2 Plasma Coagulation Factor
1.3 Global Blood Coagulants Market Size by Type
1.3.1 Global Blood Coagulants Market Size Overview by Type (2018-2029)
1.3.2 Global Blood Coagulants Historic Market Size Review by Type (2018-2023)
1.3.3 Global Blood Coagulants Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Blood Coagulants Sales Breakdown by Type (2018-2023)
1.4.2 Europe Blood Coagulants Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Blood Coagulants Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Blood Coagulants Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Blood Coagulants Sales Breakdown by Type (2018-2023)
2 Global Blood Coagulants Market Competition by Company
2.1 Global Top Players by Blood Coagulants Sales (2018-2023)
2.2 Global Top Players by Blood Coagulants Revenue (2018-2023)
2.3 Global Top Players by Blood Coagulants Price (2018-2023)
2.4 Global Top Manufacturers Blood Coagulants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Blood Coagulants Market Competitive Situation and Trends
2.5.1 Blood Coagulants Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Blood Coagulants Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Coagulants as of 2022)
2.7 Date of Key Manufacturers Enter into Blood Coagulants Market
2.8 Key Manufacturers Blood Coagulants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Blood Coagulants Status and Outlook by Region
3.1 Global Blood Coagulants Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Blood Coagulants Historic Market Size by Region
3.2.1 Global Blood Coagulants Sales in Volume by Region (2018-2023)
3.2.2 Global Blood Coagulants Sales in Value by Region (2018-2023)
3.2.3 Global Blood Coagulants Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Blood Coagulants Forecasted Market Size by Region
3.3.1 Global Blood Coagulants Sales in Volume by Region (2024-2029)
3.3.2 Global Blood Coagulants Sales in Value by Region (2024-2029)
3.3.3 Global Blood Coagulants Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Blood Coagulants by Sale Channel
4.1 Blood Coagulants Market Segment by Sale Channel
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Other
4.2 Global Blood Coagulants Market Size by Sale Channel
4.2.1 Global Blood Coagulants Market Size Overview by Sale Channel (2018-2029)
4.2.2 Global Blood Coagulants Historic Market Size Review by Sale Channel (2018-2023)
4.2.3 Global Blood Coagulants Forecasted Market Size by Sale Channel (2024-2029)
4.3 Key Regions Market Size Segment by Sale Channel
4.3.1 North America Blood Coagulants Sales Breakdown by Sale Channel (2018-2023)
4.3.2 Europe Blood Coagulants Sales Breakdown by Sale Channel (2018-2023)
4.3.3 Asia-Pacific Blood Coagulants Sales Breakdown by Sale Channel (2018-2023)
4.3.4 Latin America Blood Coagulants Sales Breakdown by Sale Channel (2018-2023)
4.3.5 Middle East and Africa Blood Coagulants Sales Breakdown by Sale Channel (2018-2023)
5 North America Blood Coagulants by Country
5.1 North America Blood Coagulants Historic Market Size by Country
5.1.1 North America Blood Coagulants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Blood Coagulants Sales in Volume by Country (2018-2023)
5.1.3 North America Blood Coagulants Sales in Value by Country (2018-2023)
5.2 North America Blood Coagulants Forecasted Market Size by Country
5.2.1 North America Blood Coagulants Sales in Volume by Country (2024-2029)
5.2.2 North America Blood Coagulants Sales in Value by Country (2024-2029)
6 Europe Blood Coagulants by Country
6.1 Europe Blood Coagulants Historic Market Size by Country
6.1.1 Europe Blood Coagulants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Blood Coagulants Sales in Volume by Country (2018-2023)
6.1.3 Europe Blood Coagulants Sales in Value by Country (2018-2023)
6.2 Europe Blood Coagulants Forecasted Market Size by Country
6.2.1 Europe Blood Coagulants Sales in Volume by Country (2024-2029)
6.2.2 Europe Blood Coagulants Sales in Value by Country (2024-2029)
7 Asia-Pacific Blood Coagulants by Region
7.1 Asia-Pacific Blood Coagulants Historic Market Size by Region
7.1.1 Asia-Pacific Blood Coagulants Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Blood Coagulants Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Blood Coagulants Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Blood Coagulants Forecasted Market Size by Region
7.2.1 Asia-Pacific Blood Coagulants Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Blood Coagulants Sales in Value by Region (2024-2029)
8 Latin America Blood Coagulants by Country
8.1 Latin America Blood Coagulants Historic Market Size by Country
8.1.1 Latin America Blood Coagulants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Blood Coagulants Sales in Volume by Country (2018-2023)
8.1.3 Latin America Blood Coagulants Sales in Value by Country (2018-2023)
8.2 Latin America Blood Coagulants Forecasted Market Size by Country
8.2.1 Latin America Blood Coagulants Sales in Volume by Country (2024-2029)
8.2.2 Latin America Blood Coagulants Sales in Value by Country (2024-2029)
9 Middle East and Africa Blood Coagulants by Country
9.1 Middle East and Africa Blood Coagulants Historic Market Size by Country
9.1.1 Middle East and Africa Blood Coagulants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Blood Coagulants Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Blood Coagulants Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Blood Coagulants Forecasted Market Size by Country
9.2.1 Middle East and Africa Blood Coagulants Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Blood Coagulants Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Blood Coagulants Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Blood Coagulants Products Offered
10.1.5 Pfizer Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Blood Coagulants Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer Blood Coagulants Products Offered
10.2.5 Bayer Recent Development
10.3 Novo Nordisk
10.3.1 Novo Nordisk Company Information
10.3.2 Novo Nordisk Introduction and Business Overview
10.3.3 Novo Nordisk Blood Coagulants Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novo Nordisk Blood Coagulants Products Offered
10.3.5 Novo Nordisk Recent Development
10.4 Takeda
10.4.1 Takeda Company Information
10.4.2 Takeda Introduction and Business Overview
10.4.3 Takeda Blood Coagulants Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Takeda Blood Coagulants Products Offered
10.4.5 Takeda Recent Development
10.5 SOBI
10.5.1 SOBI Company Information
10.5.2 SOBI Introduction and Business Overview
10.5.3 SOBI Blood Coagulants Sales, Revenue and Gross Margin (2018-2023)
10.5.4 SOBI Blood Coagulants Products Offered
10.5.5 SOBI Recent Development
10.6 Octapharma
10.6.1 Octapharma Company Information
10.6.2 Octapharma Introduction and Business Overview
10.6.3 Octapharma Blood Coagulants Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Octapharma Blood Coagulants Products Offered
10.6.5 Octapharma Recent Development
10.7 CSL
10.7.1 CSL Company Information
10.7.2 CSL Introduction and Business Overview
10.7.3 CSL Blood Coagulants Sales, Revenue and Gross Margin (2018-2023)
10.7.4 CSL Blood Coagulants Products Offered
10.7.5 CSL Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Blood Coagulants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Blood Coagulants Industrial Chain Analysis
11.4 Blood Coagulants Market Dynamics
11.4.1 Blood Coagulants Industry Trends
11.4.2 Blood Coagulants Market Drivers
11.4.3 Blood Coagulants Market Challenges
11.4.4 Blood Coagulants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Blood Coagulants Distributors
12.3 Blood Coagulants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
